Literature DB >> 9019160

Sequence requirements for alpha-fetoprotein gene expression during liver regeneration.

Y Lin1, D K Jin, J Vacher, M H Feuerman.   

Abstract

The alpha-fetoprotein (AFP) gene is expressed in fetal liver and in adult liver undergoing regeneration or tumorigenesis. It has been shown previously that three distal enhancers, a proximal promoter, and a dominant negative postnatal repressor element are required for the tissue-specific and developmental regulation of AFP gene expression. Using transgenic mice, we have determined the sequence requirements for AFP gene induction during liver regeneration. Two DNA sequences were found in all transgenes appropriately regulated in response to liver regeneration: a distal sequence between 1010 and 838 bp upstream of the structural gene and a proximal sequence within 118 bp of the transcriptional initiation site. In situ hybridization analysis showed that transgene expression during liver regeneration was first found in all hepatocytes and then localized to perinecrotic hepatocytes surrounding the central vein. This pattern of expression is reminiscent of that observed after birth for the transgenes, suggesting that repression of AFP gene expression after birth and liver injury may be regulated by similar mechanisms.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 9019160

Source DB:  PubMed          Journal:  Cell Growth Differ        ISSN: 1044-9523


  3 in total

1.  S-Phase progression mediates activation of a silenced gene in synthetic nuclei.

Authors:  A J Crowe; J L Piechan; L Sang; M C Barton
Journal:  Mol Cell Biol       Date:  2000-06       Impact factor: 4.272

2.  p53-targeted LSD1 functions in repression of chromatin structure and transcription in vivo.

Authors:  Wen-Wei Tsai; Thi T Nguyen; Yang Shi; Michelle Craig Barton
Journal:  Mol Cell Biol       Date:  2008-06-23       Impact factor: 4.272

3.  alpha-Fetoprotein gene sequences mediating Afr2 regulation during liver regeneration.

Authors:  D K Jin; J Vacher; M H Feuerman
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-21       Impact factor: 11.205

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.